Ralph Toelg

Showing 1-10 of 10 articles

Outcomes of rotational atherectomy versus modified balloon angioplasty in severely calcified coronary lesions based on target lesion location: a post hoc analysis of the PREPARE-CALC randomised trial

Rheude T, Toelg R, Byrne R, Allali A, Wiebe J, Sulimov D, Voll F, Cassese S, Richardt G, Kastrati A, Abdel-Wahab M

July 17, 2020 | 10.4244/EIJ-D-19-00488

Coronary interventions

Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial

Haude M, Ince H, Toelg R, Lemos P, von Birgelen C, Christiansen E, Wijns W, Neumann F, Eeckhout E, Garcia-Garcia H, Waksman R

February 7, 2020 | 10.4244/EIJ-D-18-01000

Coronary interventions

BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months

Saito S, Toelg R, Witzenbichler B, Haude M, Masotti M, Salmeron R, Witkowski A, Uematsu M, Takahashi A, Waksman R, Slagboom T

December 6, 2019 | 10.4244/EIJ-D-18-01214

Coronary interventions

Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III

Haude M, Ince H, Kische S, Abizaid A, Toelg R, Lemos P, Van Mieghem N, Verheye S, von Birgelen C, Christiansen E, Wijns W, Garcia-Garcia H, Waksman R

July 20, 2017 | 10.4244/EIJ-D-17-00254

Interventions for valvular disease

Impact of femoral artery puncture using digital subtraction angiography and road mapping on vascular and bleeding complications after transfemoral transcatheter aortic valve implantation

El-Mawardy M, Schwarz B, Landt M, Sulimov D, Kebernik J, Allali A, Becker B, Toelg R, Richardt G, Abdel-Wahab M

January 20, 2017 | 10.4244/EIJ-D-15-00412

Coronary artery treatment with paclitaxel-coated balloon using a BTHC excipient: clinical results of the international real-world DELUX registry

Toelg R, Merkely B, Erglis A, Hoffmann S, Bruno H, Kornowski R, Slagboom T, Naber C, Witzenbichler B, Graf K, Richardt G, Hehrlein C

September 28, 2014 | 10.4244/EIJV10I5A102

Comparison of bivalirudin and heparin in patients undergoing rotational atherectomy: a subanalysis of the randomised ROTAXUS trial

Akin I, Khattab A, Buettner H, Toelg R, Geist V, Neumann F, Richardt G, Abdel-Wahab M

August 19, 2014 | 10.4244/EIJV10I4A79

Stuck rotablator: the nightmare of rotational atherectomy

Sulimov D, Abdel-Wahab M, Toelg R, Kassner G, Geist V, Richardt G

June 28, 2013 | 10.4244/EIJV9I2A41

Determination of haemodynamic significance of intermediate coronary lesions using three-dimensional coronary reconstruction

Saad M, Toelg R, Khattab A, Kassner G, Abdel-Wahab M, Richardt G

November 15, 2009 | 10.4244/EIJV5I5A93

Relationship between cardiovascular risk as predicted by established risk scores and coronary artery plaque composition as detected by virtual histology intravascular ultrasound analysis: the PREDICT pilot study

Abdel-Wahab M, Khattab A, Liska B, Toelg R, El-Hammady W, Farag N, Geist V, Ramzy A, Richardt G

January 20, 2008

Latest news

NEW ISSUE

Atherectomies, in-stent restenosis, stent thrombosis, coronary physiology in TAVI and heart failure

July 17, 2020

NEW

Ahead of print: New technique of percutaneous mitral valvuloplasty

C. Aurigemma et al

July 29, 2020

Editorial

Rotational atherectomy and the myth of Sisyphus

Antonio Serra

July 29, 2020

Guidance Papers

Guidelines, consensus & position papers

June 25, 2020

Find the latest trials:

TICAKOREA, PEPCAD NSTEMI, CROSS-AMI, PARTNER-2A 5 years, and more

July 1, 2020

Editorial

Fractional flow reserve substitutes in aortic stenosis

Nils P. Johnson

July 29, 2020

JAA

This Week's JAA's: Real-world Use of the Evolut PRO Valve...